title: DHPG treatment of kidney transplant recipients with severe CMV infection.
authors.affiliation: Nephrology Department, Hôpital Henri Mondor, Créteil, France.
authors.forename: P
authors.initials: P
authors.lastname: Lang
authors.forename: C
authors.initials: C
authors.lastname: Buisson
authors.forename: G
authors.initials: G
authors.lastname: Rostoker
authors.forename: A
authors.initials: A
authors.lastname: Ben Maadi
authors.forename: G
authors.initials: G
authors.lastname: Fruchaud
authors.forename: L
authors.initials: L
authors.lastname: Deforge
authors.forename: D
authors.initials: D
authors.lastname: Chopin
authors.forename: C
authors.initials: C
authors.lastname: Abbou
authors.forename: P
authors.initials: P
authors.lastname: Romano
authors.forename: J
authors.initials: J
authors.lastname: Fleury
mesh_terms: D000212:Acyclovir / Q000031:analogs & derivatives* / Q000627:therapeutic use; D000328:Adult; D000368:Aged; D000914:Antibodies, Viral / Q000032:analysis; D000998:Antiviral Agents / Q000627:therapeutic use*; D003587:Cytomegalovirus / Q000276:immunology; D003586:Cytomegalovirus Infections / Q000188:drug therapy* / Q000209:etiology; D005260:Female; D015774:Ganciclovir; D006801:Humans; D016030:Kidney Transplantation; D008297:Male; D008875:Middle Aged
chemical_list: D000914:Antibodies, Viral; D000998:Antiviral Agents; D015774:Ganciclovir; D000212:Acyclovir